Kathleen OLoughlin - 08 Feb 2022 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Kathleen T. O'Loughlin
Issuer symbol
BIOL
Transactions as of
08 Feb 2022
Net transactions value
$0
Form type
4
Filing time
10 Feb 2022, 14:03:21 UTC
Previous filing
26 Aug 2021
Next filing
13 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +90,000 $0.000000 90,000 08 Feb 2022 Common Stock 90,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award fully vests and is immediately exercisable on March 31, 2024.